Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole
- 1 November 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 339 (2-3) , 109-111
- https://doi.org/10.1016/s0014-2999(97)01386-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- [3H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptorsEuropean Journal of Pharmacology, 1996
- Behavioural response to SKF 38393 and quinpirole following chronic antidepressant treatmentEuropean Journal of Pharmacology, 1995
- The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline‐preferring receptorsBritish Journal of Pharmacology, 1995
- Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirolePharmacology Biochemistry and Behavior, 1994
- Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanismPsychopharmacology, 1994
- Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activityBrain Research Reviews, 1991
- Conditioning and experiential factors affecting the development of sensitization to apomorphine.Behavioral Neuroscience, 1989
- Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosisBrain Research Reviews, 1986
- Osmotic mini-pumps: A convenient program for weight-adjusted filling concentrationsBrain Research Bulletin, 1986